NTR: Reassessed P/E And Farm Headwinds Will Shape Balanced Returns Ahead

Analysts have raised our Nutrien fair value estimate to $91.99 from $88.43, as recent price target increases and rating changes suggest a reassessment of the stock's risk profile, growth outlook, and appropriate future P/E multiple.

Analyst Commentary

Recent Street research on Nutrien has become more constructive, with several firms increasing price targets or improving ratings while others remain cautious on end market conditions and sector headwinds. Here is how the bullish and bearish commentary breaks down for you as an investor.

Bullish Takeaways

Bullish analysts have raised price targets by between $3 and $12 per share in recent reports, which signals a higher view of Nutrien's potential valuation versus prior expectations.
Some recent upgrades and target hikes reference execution on internal initiatives, including what one firm called a fantastic quarter on those efforts, which supports the idea that management is delivering on its plans.
Higher targets from supportive analysts indicate increased confidence that the current P/E multiple could be supported by the company’s positioning within fertilizers and broader chemicals.
Even when ratings remain Neutral or Equal Weight, some firms still see areas for optimism tied to possible sector catalysts such as changes in purchasing managers indices, interest rate moves, or capacity rationalization in China, which they see as potential supports for fertilizer and chemicals valuations.

Bearish Takeaways

Bearish analysts, or those staying on the sidelines, have trimmed price targets by small amounts, reflecting restraint on how much upside they are willing to underwrite for Nutrien at this stage.
One firm cites a difficult near term setup for farmers, pointing to a record North American harvest and weaker crop prices into 2026, which they see as a headwind for fertilizer demand and, by extension, for Nutrien’s growth visibility.
Another cautious view comes from concerns about growing oversupply in commodities and an inconsistent backdrop for specialties, which could pressure margins and limit multiple expansion for the sector, including Nutrien.
Even where analysts outline possible positive catalysts, some explicitly warn that these are too early to rely on, which keeps their ratings and targets more restrained despite recent company level execution.

Valuation Changes

Fair value estimate has risen slightly to CA$91.99 from CA$88.43.
The discount rate has moved up modestly to 7.36% from 7.26%, indicating a slightly higher required return assumption.
Revenue growth is now set at 1.66% compared with the prior 2.55% assumption.
The net profit margin has been adjusted to 7.01% from 7.34%.
The future P/E has increased to 20.53x from 18.10x, reflecting a higher assumed valuation multiple.

Strong global food demand and adoption of advanced agriculture practices are driving steady growth, higher-margin sales, and improved revenue stability for Nutrien.
Operational efficiencies, cost reductions, and disciplined capital allocation are enhancing margins, free cash flow, and shareholder returns over the long term.
Regulatory pressures, shifting agricultural practices, market dependency, execution risks, and lack of diversification threaten Nutrien's profitability, revenue growth, and future market position.

Catalysts

About Nutrien

Provides crop inputs and services.What are the underlying business or industry changes driving this perspective?

Global food demand is structurally supporting long-term fertilizer use: Increasing world population and rising global food demand, particularly in emerging markets, are creating sustained demand for essential crop nutrients like potash and nitrogen-Nutrien's core products-which should underpin stable or growing sales volumes and improve revenue visibility.
Adoption of yield-maximizing and resource-optimizing ag practices: The drive to maximize yields per acre due to climate change, shrinking arable land, and erratic weather is boosting fertilizer adoption and incentivizing precision agriculture. Nutrien's investments in automation, precision ag, and efficiency position it to capture higher-margin, premium sales and expand net margins over time.
Tight industry supply and high operating efficiency: Supply-side constraints, slow addition of new global capacity, and strengthening fertilizer fundamentals have resulted in rising prices and reduced competitive threats, while Nutrien's mine automation and debottlenecking initiatives are lowering per-ton production costs, supporting both top-line growth and margin expansion.
Operational cost reductions and portfolio optimization: Ongoing SG&A and capex reductions, accelerated cost savings programs, and modernization of distribution structures (especially in Brazil and North America) are already increasing adjusted EBITDA and will structurally enhance net margins and free cash flow generation into 2026.
Enhanced shareholder returns and disciplined capital allocation: Consistent share buybacks, durable dividend growth, and asset divestitures are directly increasing free cash flow per share and underpin rising earnings per share, signaling management's confidence in long-term earnings growth and balance sheet strength.

Nutrien Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

Analysts are assuming Nutrien's revenue will grow by 3.2% annually over the next 3 years.
Analysts assume that profit margins will increase from 5.4% today to 8.5% in 3 years time.
Analysts expect earnings to reach $2.3 billion (and earnings per share of $4.87) by about September 2028, up from $1.4 billion today. However, there is some disagreement amongst the analysts with the more bearish ones expecting earnings as low as $1.6 billion.
In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 15.2x on those 2028 earnings, down from 20.3x today. This future PE is greater than the current PE for the US Chemicals industry at 11.3x.
Analysts expect the number of shares outstanding to decline by 1.53% per year for the next 3 years.
To value all of this in today's terms, we will use a discount rate of 7.22%, as per the Simply Wall St company report.

Nutrien Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?

Increasing regulatory scrutiny and potential tightening of environmental regulations on fertilizer production, especially around greenhouse gas emissions and water usage, could drive higher compliance and operational costs, negatively impacting Nutrien's net margins over the long term.
Advances in regenerative agriculture, organic farming practices, and precision agriculture technologies may reduce reliance on synthetic fertilizers, leading to decreased fertilizer application rates and a potential shrinkage of Nutrien's long-term addressable market, pressuring revenue growth.
Nutrien remains highly dependent on potash and nitrogen products for the majority of its earnings; if global fertilizer prices weaken or if alternative crop nutrition solutions such as biologicals and enhanced efficiency fertilizers gain widespread adoption, Nutrien could experience significant revenue and earnings volatility.
The company's success in cost reduction and margin improvement initiatives in key markets like Brazil is contingent on favorable market conditions; any setbacks in execution or sustained market headwinds could undermine improvements in free cash flow and net margins.
Ongoing consolidation and competitive pressures in the fertilizer and crop input sector may erode Nutrien's pricing power, and failure to sufficiently diversify its product portfolio or geographic exposure-especially outside of North America-could result in stagnant or declining revenue and market share over time.

Valuation

How have all the factors above been brought together to estimate a fair value?

The analysts have a consensus price target of CA$86.165 for Nutrien based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of CA$96.39, and the most bearish reporting a price target of just CA$61.11.
In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $27.5 billion, earnings will come to $2.3 billion, and it would be trading on a PE ratio of 15.2x, assuming you use a discount rate of 7.2%.
Given the current share price of CA$78.39, the analyst price target of CA$86.17 is 9.0% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Nutrien?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Shifting Market Trends Will Shape Fertilizer Demand Amid Agricultural Cycle Uncertainty